Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
123.07
-0.22 (-0.18%)
Nov 4, 2024, 4:00 PM EST - Market closed
Sarepta Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 47.3 | -535.98 | -703.49 | -418.78 | -554.13 | -715.08 | Upgrade
|
| Depreciation & Amortization | 39.76 | 44.4 | 41.86 | 38.02 | 26.46 | 24.05 | Upgrade
|
| Other Amortization | - | - | - | - | 0.45 | 0.45 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -102 | - | -102 | -107.98 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 173.24 | Upgrade
|
| Loss (Gain) From Sale of Investments | 27.71 | 30.32 | 2.58 | 4.49 | - | - | Upgrade
|
| Stock-Based Compensation | 185.06 | 182.51 | 233.02 | 113.94 | 108.07 | 78.6 | Upgrade
|
| Other Operating Activities | -16.33 | 360.84 | 140.16 | 19.33 | 80.54 | 49.15 | Upgrade
|
| Change in Accounts Receivable | -123.19 | -185.7 | -61.64 | -51.65 | -10.46 | -41.84 | Upgrade
|
| Change in Inventory | -283.69 | -147.71 | -50.78 | -83.77 | -60.58 | -45.93 | Upgrade
|
| Change in Accounts Payable | 28.28 | -50.14 | 147.57 | 23.3 | 42 | 122.98 | Upgrade
|
| Change in Unearned Revenue | -82.95 | -86.83 | -89.24 | -89.24 | 749.43 | - | Upgrade
|
| Change in Other Net Operating Assets | -218.45 | -10.71 | 14.62 | 103.2 | -166.33 | -102.09 | Upgrade
|
| Operating Cash Flow | -396.5 | -500.99 | -325.35 | -443.17 | 107.47 | -456.46 | Upgrade
|
| Capital Expenditures | -110.32 | -76.11 | -30.82 | -38.49 | -82.2 | -59.63 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -172.56 | Upgrade
|
| Sale (Purchase) of Intangibles | -21.1 | 90.76 | -1.43 | 99.69 | 108.07 | - | Upgrade
|
| Investment in Securities | -23.24 | -180.46 | -1,015 | 434.21 | -144.09 | 521.99 | Upgrade
|
| Other Investing Activities | - | - | - | - | -3.5 | -3.08 | Upgrade
|
| Investing Cash Flow | -154.66 | -165.8 | -1,047 | 495.41 | -121.72 | 286.73 | Upgrade
|
| Long-Term Debt Issued | - | - | 1,127 | - | 291.15 | 245.63 | Upgrade
|
| Long-Term Debt Repaid | - | - | -823.23 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 304.17 | - | 291.15 | 245.63 | Upgrade
|
| Issuance of Common Stock | 79.41 | 51.25 | 30.04 | 569.33 | 396.01 | 401.96 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -7.77 | -4.8 | -4.34 | Upgrade
|
| Other Financing Activities | - | 73.76 | -101.7 | - | -0.04 | -0.69 | Upgrade
|
| Financing Cash Flow | 79.41 | 125 | 232.51 | 561.57 | 682.32 | 642.55 | Upgrade
|
| Net Cash Flow | -471.75 | -541.79 | -1,140 | 613.81 | 668.07 | 472.82 | Upgrade
|
| Free Cash Flow | -506.82 | -577.1 | -356.17 | -481.66 | 25.26 | -516.09 | Upgrade
|
| Free Cash Flow Margin | -33.68% | -46.42% | -38.17% | -68.62% | 4.68% | -135.52% | Upgrade
|
| Free Cash Flow Per Share | -5.19 | -6.25 | -4.07 | -5.93 | 0.32 | -7.01 | Upgrade
|
| Cash Interest Paid | 16.09 | 15.92 | 44.42 | 55.95 | 34.42 | 8.55 | Upgrade
|
| Cash Income Tax Paid | 17.08 | 15.08 | 1.7 | 0.58 | 2.51 | 0.93 | Upgrade
|
| Levered Free Cash Flow | -408.09 | -347.96 | -54.65 | -8.7 | -280.36 | -302.84 | Upgrade
|
| Unlevered Free Cash Flow | -395.93 | -334.2 | -21.37 | 31.01 | -242.89 | -283.67 | Upgrade
|
| Change in Net Working Capital | 513.07 | 408.38 | -71.13 | -95.1 | 51.2 | 0.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.